← Return to Aching legs from Small Fiber Neuropathy

Discussion

Aching legs from Small Fiber Neuropathy

Neuropathy | Last Active: Dec 1, 2023 | Replies (140)

Comment receiving replies
@healingone

Video transcript.

Dr. Sletten is the program director.

CHRISTOPHER SLETTEN: Hello. My name is Christopher Sletten. I am the clinical director of the Mayo Comprehensive Pain Rehabilitation Program, in Jacksonville, Florida. I'd like to take this opportunity to discuss some of our treatment and clinical options for patients with difficult to manage chronic symptoms. The Pain Rehab Program here in Florida opened in October of 2011. And we now have a capacity to treat 30 patients at a time. This program was based on the original model from Rochester, which has been in existence since 1974.

One of the things I'd like you to think about today as we discuss the treatment program is those patients of yours that have been a challenge to manage, you've run out of treatment options, you and your patient are frustrated with what to do next, and you're looking for alternatives to help them manage their symptoms on a long-term basis. Our basic treatment model is based on a cognitive behavior therapy model, with an integrated team approach. The basic components of treatment in our program include physical reconditioning, biofeedback and relaxation strategies, teaching stress management, chemical health, activity moderation, and behavioral interventions for chronic pain.

Historically, pain rehabilitation programs have treated individuals with back pain, headaches, musculoskeletal, limb pain, joint pain, abdominal pain. And certainly, those are the patients that we continue to actively treat. The past few years, we've actually broadened our treatment spectrum to include patients with chronic fatigue, non-epileptic spells, movement disorders, multiple chemical sensitivities, and even individuals with chronic GI distress, including cyclic vomiting, dyspepsia et cetera.

The program itself is a day treatment program based in the hospital. Patients attend Monday through Friday, 8:00 to 4:30, for three consecutive weeks. This is preceded by an admission day, where the patient is evaluated by all the members of the treatment team.

One thing I want to emphasize, for your information, is the fact that we use a multidisciplinary team approach. And in fact, it's very highly interdisciplinary. We use physical therapy, occupational therapy, psychology, nursing, and medical staff in our treatment team. Physical therapy engages in a reconditioning approach that primarily focuses on whole body exercises, stretching, strengthening. But we also minimize and actually de-emphasize the use of modalities and hands-on physical therapy. Occupational therapy employs the use of moderation, modification, and time management, and other strategies, to help the patient engage in a broad range of daily activities.

From a psychological perspective, the groups emphasize stress management, behavioral management, cognitive approaches to managing pain, and coping with chronic symptoms. Our medical team includes the RNs and physician's assistants, and physicians. This group of individuals monitor the patient's health status, monitor medication changes, and form the foundation for our medical supervision of our complex patients.

Throughout the whole history of pain rehabilitation, we focus on three pillars of treatment. And I've alluded to those briefly. We emphasize medication elimination. Particularly with the strong psychoactive medications, we actively and thoroughly eliminate opiate analgesics, benzodiazepines, sleeping medications, stimulants. We also reduce and eliminate muscle relaxers, anti-inflammatories, and other symptom-managing agents. Our physical therapy regimen includes, as I mentioned, physical reconditioning. And we work with the individuals to change their approach to their chronic symptoms, from one of symptom management to lifestyle management.

We have a very active evaluation and admission process. Most of our patients wait a matter of days to a few weeks for admission. We're very keenly interested in getting the appropriate patient into treatment as quickly as possible, since many have been suffering for a great many years.

Our outcomes have been well established. The treatment literature for the effectiveness of pain rehab is well established. We have consistently shown a significant decrease in pain scores, depression scores. We've also seen a significant improvement in daily activities and the patient's perception of control over their pain state.

Research activities, both here and in Rochester, continue. and the maintenance of these gains is also quite profound. Over 75% of our patients are still showing treatment improvement one year after the program. Additionally, we work very actively to help our patients reduce their reliance on the health care system. We actively educate them about the appropriate use of primary care, de-emphasizing continued utilization of specialty care and symptom management treatment.

Finally, what happens after the program, all of our patients are invited to aftercare, which occurs, at this point, on an every other month basis for two hours in an afternoon. And patients are encouraged to return to meet with the staff and other graduates of the program. This time we found to be very clinically effective for the patients to experience support from staff and other graduates, and also somewhat of a refresher course in the principles of pain rehabilitation.

Any questions or interest in this program can be directed to the Pain Rehabilitation Center. We are very interested in assisting you and your patients to have them have a better future and a better outcome in dealing with their chronic symptoms. Thank you very much.

PUBLISHED

May 5, 2015

Refer a Patient
NPI Number Required
Related Videos

Practical evaluation and management of the patient with spasticity
Practical evaluation and management of the patient with spasticity

Mayo Clinic physiatrists Billie A. Schultz, M.D., and Michael C. Wainberg, M.D., present clinical and objective measures commonly used to assess patients with spasticity and discuss multidisciplinary interventions for management.

Improving muscle health
Improving muscle health

Nathan K. LeBrasseur, M.S., Ph.D., associate professor and co-chair of research in the Department of Physical Medicine and Rehabilitation, Mayo Clinic College of Medicine, discusses age- and disease-associated muscle loss.

Gene therapy for neuromuscular diseases: Surprising lessons learned from dogs
Gene therapy for neuromuscular diseases: Surprising lessons learned from dogs

Martin Childers, D.O., Ph.D., is joined by Carmen M. Terzic, M.D., Ph.D., to discuss his gene therapy work.

Age-related muscle loss
Age-related muscle loss

Nathan K. LeBrasseur, M.S., Ph.D., discusses research at the Robert and Arlene Kogod Center on Aging with Carmen M. Terzic, M.D., Ph.D., chair of Physical Medicine and Rehabilitation, at the 2015 Fourth Annual Symposium on Regenerative Rehabilitation.

Gene therapy for cartilage regeneration
Gene therapy for cartilage regeneration

Christopher H. Evans, Ph.D., and Carmen M. Terzic, M.D., Ph.D., discuss gene therapy for cartilage regeneration at the 2015 Fourth Annual Symposium on Regenerative Rehabilitation.

Using ultrasound elastography to quantify passive muscle stiffness in children: Effect of spasticity and botulinum toxin on muscle
Using ultrasound elastography to quantify passive muscle stiffness in children: Effect of spasticity and botulinum toxin on muscle

Joline E. Brandenburg, M.D., Physical Medicine and Rehabilitation, discusses the rationale for studying passive muscle stiffness, the effects of spasticity on muscle in children with cerebral palsy.

Use of exoskeletons in individuals with spinal cord injuries
Use of exoskeletons in individuals with spinal cord injuries

A three-phase clinical trial explores a lightweight exoskeleton system to evaluate its impact on the lives of people with mobility issues due to spinal cord injuries.

Adipose-derived stem cell treatment for osteoarthritic knees
Adipose-derived stem cell treatment for osteoarthritic knees

Jay Smith, M.D., describes a clinical trial to evaluate the safety and efficacy of adipose-derived mesenchymal stromal cell injections as a treatment for people with osteoarthritic knees.

Enhancing stem cell therapeutics for volumetric muscle loss
Enhancing stem cell therapeutics for volumetric muscle loss

Thomas Rando, M.D., Ph.D., chief of neurology and director, Rehabilitation Research and Development, Stanford University, and Carmen M. Terzic, M.D., Ph.D., chair of Mayo Clinic Physical Medicine and Rehabilitation, discuss enhancing stem ...

HELPFUL LINKS

Request An Appointment
Make A Donation
Contact Us
About Mayo Clinic
Employees
Site Map
Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.

Terms and Conditions
Privacy Policy
Notice of Privacy Practices

Mayo Clinic is a not-for-profit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.

Advertising and sponsorship policy
Advertising and sponsorship opportunities

A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Powered by the BroadcastMed Network
BroadcastMed Privacy Policy
© 1998-2020 Mayo Foundation for Medical Education and Research. All rights reserved.

Jump to this post


Replies to "Video transcript. Dr. Sletten is the program director. CHRISTOPHER SLETTEN: Hello. My name is Christopher Sletten...."

W O W ! ! ! Thank you so much for posting such helpful, awesome information. What a dream this would be. If only Mayo offered scholarships.